NCT01083693 - Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis

Trial Locations (20)

Site Reference ID/Investigator # 32372, Amstetten

Site Reference ID/Investigator # 32368, Bludenz

Site Reference ID/Investigator # 32367, Gloggnitz

Site Ref # / Investigator 37123, Graz

Site Ref # / Investigator 37125, Innsbruck

Site Reference ID/Investigator # 32375, Klagenfurt

Site Reference ID/Investigator # 32365, Linz

Site Reference ID/Investigator # 32369, Linz

Site Reference ID/Investigator # 32371, Linz

Site Reference ID/Investigator # 32376, Linz

Site Reference ID/Investigator # 32373, Neudorf

Site Reference ID/Investigator # 32364, Salzburg

Site Reference ID/Investigator # 18782, Vienna

Site Reference ID/Investigator # 32363, Vienna

Site Reference ID/Investigator # 32377, Vienna

Site Reference ID/Investigator # 32378, Vienna

Site Reference ID/Investigator # 32366, Vienna

Site Reference ID/Investigator # 32374, Vöcklabruck

Site Reference ID/Investigator # 32370, Weiz

Site Ref # / Investigator 37124, Wels